12-12813411-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_016355.4(DDX47):ā€‹c.44A>Cā€‹(p.Gln15Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 1,461,222 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.000018 ( 1 hom. )

Consequence

DDX47
NM_016355.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.80
Variant links:
Genes affected
DDX47 (HGNC:18682): (DEAD-box helicase 47) This gene encodes a member of the DEAD box protein family. DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene can shuttle between the nucleus and the cytoplasm, and has an RNA-independent ATPase activity. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
APOLD1 (HGNC:25268): (apolipoprotein L domain containing 1) APOLD1 is an endothelial cell early response protein that may play a role in regulation of endothelial cell signaling and vascular function (Regard et al., 2004 [PubMed 15102925]).[supplied by OMIM, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.094059855).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DDX47NM_016355.4 linkuse as main transcriptc.44A>C p.Gln15Pro missense_variant 1/12 ENST00000358007.7 NP_057439.2 Q9H0S4-1A0A024RAS3
DDX47NM_201224.2 linkuse as main transcriptc.44A>C p.Gln15Pro missense_variant 1/11 NP_957518.1 Q9H0S4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DDX47ENST00000358007.7 linkuse as main transcriptc.44A>C p.Gln15Pro missense_variant 1/121 NM_016355.4 ENSP00000350698.3 Q9H0S4-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.0000160
AC:
4
AN:
249706
Hom.:
0
AF XY:
0.0000222
AC XY:
3
AN XY:
134956
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000987
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000178
AC:
26
AN:
1461222
Hom.:
1
Cov.:
30
AF XY:
0.0000234
AC XY:
17
AN XY:
726830
show subpopulations
Gnomad4 AFR exome
AF:
0.000389
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000581
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000225
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 09, 2021The c.44A>C (p.Q15P) alteration is located in exon 1 (coding exon 1) of the DDX47 gene. This alteration results from a A to C substitution at nucleotide position 44, causing the glutamine (Q) at amino acid position 15 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
17
DANN
Benign
0.78
DEOGEN2
Benign
0.063
.;T;T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.68
T;T;T
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.094
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;L;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.046
Sift
Benign
0.15
T;T;T
Sift4G
Benign
0.27
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.33
MVP
0.25
MPC
0.24
ClinPred
0.070
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.64
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs758831201; hg19: chr12-12966345; API